Evidence map›Paper›PMID 30361616›Full record

ArticleCell death and differentiation2019

Mcl-1 and Bcl-xL are essential for survival of the developing nervous system.

Lauren C Fogarty, Robert T Flemmer, Brittany A Geizer, Maria Licursi, Ahila Karunanithy, Joseph T Opferman, Kensuke Hirasawa, Jacqueline L Vanderluit

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cell death in glioblastoma and the central nervous system.Cellular oncology (Dordrecht, Netherlands) · 2025
    Review
  7. MCL-1 regulates cellular transitions during oligodendrocyte development.bioRxiv : the preprint server for biology · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lauren C FogartyDivision of BioMedical Sciences, Memorial University, 300 Prince Philip Drive, St. John's, NF, A1B 3V6, Canada.
Robert T FlemmerDivision of BioMedical Sciences, Memorial University, 300 Prince Philip Drive, St. John's, NF, A1B 3V6, Canada.
Brittany A GeizerDivision of BioMedical Sciences, Memorial University, 300 Prince Philip Drive, St. John's, NF, A1B 3V6, Canada.
Maria LicursiDivision of BioMedical Sciences, Memorial University, 300 Prince Philip Drive, St. John's, NF, A1B 3V6, Canada.
Ahila KarunanithyDivision of BioMedical Sciences, Memorial University, 300 Prince Philip Drive, St. John's, NF, A1B 3V6, Canada.
Joseph T OpfermanDepartment of Cellular and Molecular Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.
Kensuke HirasawaDivision of BioMedical Sciences, Memorial University, 300 Prince Philip Drive, St. John's, NF, A1B 3V6, Canada.
Jacqueline L VanderluitDivision of BioMedical Sciences, Memorial University, 300 Prince Philip Drive, St. John's, NF, A1B 3V6, Canada. j.vanderluit@mun.ca.
Memorial University of Newfoundland · CASt. Jude Children's Research Hospital · US

Funding

CIHR 245727
6 · The paper itself

Abstract

During neurogenesis, proliferating neural precursor cells (NPC) exit the cell cycle and differentiate into postmitotic neurons. The proteins that regulate cell survival through the stages of differentiation, however, are still poorly understood. Here, we examined the roles of the anti-apoptotic Bcl-2 proteins, Mcl-1 and Bcl-xL, in promoting survival as cells progress through the stages of neurogenesis in the mouse embryonic central nervous system. We used Nestin-mediated, nervous system-specific conditional deletion of mcl-1, bcl-x or both to identify their distinct and overlapping roles. Individual conditional deletion of mcl-1 (MKO) and bcl-x (BKO) suggested sequential roles in promoting cell survival during developmental neurogenesis. In the MKO embryo, apoptosis begins at embryonic day 10 (E10) in the proliferating NPC population throughout the entire developing nervous system. In the BKO embryo, apoptosis begins later at E11 within the postmitotic neuron populations. In the double (mcl-1 and bcl-x) conditional knockout (DKO), cell death extended throughout both proliferating and non-proliferating cell populations resulting in embryonic lethality at E12, earlier than in either the MKO or BKO. Apoptotic cell death of the entire central nervous system in the DKO demonstrates that both genes are necessary for cell survival during developmental neurogenesis. To determine whether Mcl-1 and Bcl-xL have overlapping anti-apoptotic roles during neurogenesis, we examined the impact of gene dosage. Loss of a single bcl-x allele in the MKO embryo exasperated apoptotic cell death within the NPC population revealing a novel anti-apoptotic role for Bcl-xL in proliferating NPCs. Cells were rescued from apoptosis in both the MKO and BKO embryos by breeding with the Bax null mouse line indicating that Mcl-1 and Bcl-xL have a common pro-apoptotic target during developmental neurogenesis. Taken together, these findings demonstrate that Mcl-1 and Bcl-xL are the two essential anti-apoptotic Bcl-2 proteins required for the survival of the developing mammalian nervous system.

Indexed as

Animalsbcl-X ProteinCell DifferentiationCell SurvivalCentral Nervous SystemMiceMice, Inbred C57BLMyeloid Cell Leukemia Sequence 1 ProteinNeuronsBcl2l1 protein, mousebcl-X ProteinMcl1 protein, mouseMyeloid Cell Leukemia Sequence 1 Protein

Identifiers

PMID30361616
PMCPMC6748126
OpenAlexW2898390028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.